Biohit
2.92 EUR
+1.04 %
4,930 following
Corporate customer
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
+1.04 %
-15.85 %
-20.87 %
-18.44 %
-3.95 %
-5.50 %
+46.00 %
+25.86 %
-43.85 %
Biohit operates in the medical technology sector. The company develops and manufactures laboratory equipment, consumables and diagnostic analysis systems adapted for research, healthcare and industrial laboratories. In addition to its main business, it offers technical support, maintenance and training services within the aforementioned field of work. The largest operations are conducted in the Nordic market. The company has its headquarters in Helsinki.
Read moreMarket cap
44.38M EUR
Turnover
39K EUR
P/E (adj.) (26e)
20.01
EV/EBIT (adj.) (26e)
14
P/B (26e)
2.57
EV/S (26e)
2.16
Dividend yield-% (26e)
1.5 %
Coverage
Analyst
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
3.6
2026
General meeting '26
5.8
2026
Interim report Q2'26
Risk
Business risk
Valuation risk
Low
High
All
Research
Press releases
ShowingAll content types
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2025
Biohit Q4'25 preview: Back on the growth path from the middle of a sandstorm
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
